These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36759059)

  • 21. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.
    da Silva BV; Silva LB; de Oliveira DB; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    Mycopathologia; 2015 Dec; 180(5-6):333-43. PubMed ID: 26138435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidaemia due to Candida parapsilosis species complex at a hospital in Brazil: Clinical characteristics and antifungal susceptibility profile.
    Alencar DSO; Tsujisaki RAS; Spositto FLE; Nunes MO; Almeida AA; Martins MDA; Melhem MSC; Chang MR
    Rev Iberoam Micol; 2017; 34(2):106-108. PubMed ID: 28214273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis.
    Miranda-Cadena K; Marcos-Arias C; Mateo E; Aguirre JM; Quindós G; Eraso E
    Arch Oral Biol; 2018 Nov; 95():100-107. PubMed ID: 30096698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.
    Lockhart SR; Messer SA; Pfaller MA; Diekema DJ
    J Clin Microbiol; 2008 Aug; 46(8):2659-64. PubMed ID: 18562582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and antifungal susceptibility testing of Candida haemulonii complex isolated from clinical samples.
    Ruiz de Alegría-Puig C; Rodríguez-Lozano J; Agüero-Balbin J
    Folia Microbiol (Praha); 2024 Feb; 69(1):165-171. PubMed ID: 38148373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the Vitek-MS™ system in the identification of Candida isolates from bloodstream infections.
    Ruiz de Alegría Puig C; Agüero-Balbín J; Fernández-Mazarrasa C; Martínez-Martínez L
    Rev Iberoam Micol; 2018; 35(3):130-133. PubMed ID: 30343836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility.
    Ruiz LS; Khouri S; Hahn RC; da Silva EG; de Oliveira VK; Gandra RF; Paula CR
    Mycopathologia; 2013 Apr; 175(3-4):231-9. PubMed ID: 23404576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity.
    Gil-Alonso S; Quindós G; Cantón E; Eraso E; Jauregizar N
    Rev Iberoam Micol; 2019; 36(1):24-29. PubMed ID: 30837186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years.
    Demirci-Duarte S; Arikan-Akdagli S; Gülmez D
    Mycoses; 2021 Aug; 64(8):823-830. PubMed ID: 33934400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis.
    Asadzadeh M; Ahmad S; Hagen F; Meis JF; Al-Sweih N; Khan Z
    PLoS One; 2015; 10(11):e0142880. PubMed ID: 26580965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
    Bonfietti LX; Martins MDA; Szeszs MW; Pukiskas SBS; Purisco SU; Pimentel FC; Pereira GH; Silva DC; Oliveira L; Melhem MSC
    J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Candida parapsilosis complex isolates.
    de Toro M; Torres MJ; Maite R; Aznar J
    Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida parapsilosis complex in veterinary practice: A historical overview, biology, virulence attributes and antifungal susceptibility traits.
    Cordeiro RA; Sales JA; Castelo-Branco DSCM; Brilhante RSN; Ponte YB; Dos Santos Araújo G; Mendes PBL; Pereira VS; Alencar LP; Pinheiro AQ; Sidrim JJC; Rocha MFG
    Vet Microbiol; 2017 Dec; 212():22-30. PubMed ID: 29173584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
    Moris DV; Melhem MSC; Martins MA; Souza LR; Kacew S; Szeszs MW; Carvalho LR; Pimenta-Rodrigues MV; Berghs HAM; Mendes RP
    J Med Microbiol; 2012 Dec; 61(Pt 12):1758-1765. PubMed ID: 22956748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
    Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
    J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of biofilm-producing ability of clinical isolates of Candida parapsilosis species complex.
    Modiri M; Khodavaisy S; Barac A; Akbari Dana M; Nazemi L; Aala F; Salehi M; Rezaie S
    J Mycol Med; 2019 Jun; 29(2):140-146. PubMed ID: 30871787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular identification and in vitro antifungal susceptibility of blood isolates of the Candida parapsilosis species complex in Venezuela].
    Moreno X; Reviakina V; Panizo MM; Ferrara G; García N; Alarcón V; Garcés MF; Dolande M
    Rev Iberoam Micol; 2017; 34(3):165-170. PubMed ID: 28457646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.